В. В. Захаров

1 works

Sechenov First Moscow Medical University (Sechenov University), Moscow, Russia

1. Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)

   Fedin Ai, В. В. Захаров, M. М. Tanashyan +4

   ArticleNeurological Disorders and TreatmentsS S Korsakov Journal of Neurology and Psychiatry20212 citations

   ABIABI:AkademIndex/openalex/2021.article.000049